BAMLANIVIMAB

3629 reported adverse events

These side effects are most commonly reported by patients taking BAMLANIVIMAB:

# Side effect Count
0 DYSPNOEA 615
1 INFUSION RELATED REACTION 566
2 PYREXIA 403
3 OXYGEN SATURATION DECREASED 334
4 CHILLS 284
5 NAUSEA 278
6 COVID-19 261
7 COUGH 227
8 HYPOXIA 213
9 DIZZINESS 199
See all common reactions for BAMLANIVIMAB

BAMLANIVIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARDIAC ASTHMA 3 0.0219
1 BREATH SOUNDS ABSENT 2 0.0213
2 COVID-19 PNEUMONIA 186 0.0202
3 TRANSFUSION-RELATED ACUTE LUNG INJURY 3 0.0131
4 INFUSION RELATED REACTION 566 0.0114
5 FIBRIN D DIMER INCREASED 30 0.0101
6 USE OF ACCESSORY RESPIRATORY MUSCLES 3 0.0095
7 LUNG OPACITY 13 0.0091
8 POST-ACUTE COVID-19 SYNDROME 5 0.0082
9 OXYGEN SATURATION DECREASED 334 0.0078
See all enriched reactions for BAMLANIVIMAB